Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia

Infant 13-valent pneumococcal conjugate vaccination (PCV13) was introduced to the UK in 2010. Its impact on serotypes implicated in adult non-bacteraemic pneumococcal pneumonia is not known. Beginning in 2008, a 5-year prospective cohort study of adults admitted to hospital with community-acquired p...

Full description

Saved in:

Bibliographic Details
Published in:	The European respiratory journal Vol. 45; no. 6; p. 1632
Main Authors:	Rodrigo, Chamira, Bewick, Thomas, Sheppard, Carmen, Greenwood, Sonia, Mckeever, Tricia M, Trotter, Caroline L, Slack, Mary, George, Robert, Lim, Wei Shen
Format:	Journal Article
Language:	English
Published:	England 01.06.2015
Subjects:	Aged Aged, 80 and over Cohort Studies Community-Acquired Infections - epidemiology Community-Acquired Infections - prevention & control Female Hospitalization - trends Humans Incidence Male Middle Aged Pneumococcal Vaccines - therapeutic use Pneumonia, Pneumococcal - epidemiology Pneumonia, Pneumococcal - microbiology Pneumonia, Pneumococcal - prevention & control Prospective Studies Serogroup Streptococcus pneumoniae - isolation & purification
ISSN:	1399-3003, 1399-3003
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!